Correction: Trends in mortality from Alzheimer's disease and related dementias with hyperlipidemia in the United States from 1999 to 2020—A CDC WONDER database study - Summary - MDSpire

Correction: Trends in mortality from Alzheimer's disease and related dementias with hyperlipidemia in the United States from 1999 to 2020—A CDC WONDER database study

  • By

  • Junwen Wang

  • Kaide Xia

  • Dianmei Yang

  • Jing Wu

  • Longfei Liu

  • Ying Huang

  • Qing Shan

  • Haiwang Zhang

  • Yiming Wang

  • May 6, 2026

  • 0 min

Share

Objective:

To correct the order of figures presented in the study on mortality trends related to Alzheimer's disease and hyperlipidemia.

Key Findings:
  • Figures 2–6 were incorrectly ordered in the original publication.
  • The error did not affect figure captions, numbers, or in-text descriptions.
Interpretation:

The correction ensures accurate representation of data in the study.

Limitations:
  • The correction only addresses the order of figures, not the data itself.
Conclusion:

The article has been updated to reflect the correct order of figures.

Original Source(s)

Correction: Trends in mortality from Alzheimer's disease and related dementias with hyperlipidemia in the United States from 1999 to 2020—A CDC WONDER database study

  • by Junwen Wang, Kaide Xia, Dianmei Yang, Jing Wu, Longfei Liu, Ying Huang, Qing Shan, Haiwang Zhang, Yiming Wang

  • May 6, 2026

Related Content

The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions

Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone?

Targeting the miR-32533/CREB5 axis: a promising immunomodulatory and therapeutic strategy for Alzheimer’s disease